- At the Society of Robotic Surgery Conference in Strasbourg, France, SS Innovations made history by performing two complex telesurgeries across 10,000 kilometres, from IRCAD Headquarters in France to the Sri Aurobindo Institute of Medical Sciences (SAIMS) and the IRCAD National Centre in Indore, India.
- Two complex telesurgical procedures were performed – a gastric bypass and a robotic atrial septal defect (ASD) closure.
- SSI Mantra demonstrated real-time, latency-free performance, showcasing the future of remote surgical care and India’s med-tech leadership
- SSI Mantra, India’s first CDSCO-approved surgical robotic system for Telesurgery, brings precision and accessibility to complex surgical procedures.
New Delhi, 25th July 2025: In a momentous leap forward for global medical collaboration and surgical innovation, SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex intercontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System. By harnessing advanced technology, SSII is compressing the barriers of time and distance, making surgical care more accessible to patients regardless of geography and enabling expert surgeons to operate remotely with precision, reshaping the future of global healthcare delivery.
The procedures remotely connected surgical teams across nearly 10,000 kilometres, linking the Institut de recherche contre les cancers de l’appareil digestif (IRCAD) Headquarters in Strasbourg, France, to the Sri Aurobindo Institute of Medical Sciences (SAIMS) and the IRCAD National Centre in Indore, India, showcasing the SSI Mantra’s extraordinary ability to deliver high-precision surgical care across continents.
The first, a gastric bypass, was performed by Dr. Mohit Bhandari, President of IRCAD India and Founder of Mohak Bariatrics and Robotics, Indore, in just over 44 minutes, with zero complications, underscoring the system’s unmatched stability, precision, and latency-free operation.
The second procedure, a robotic atrial septal defect (ASD) closure, was performed by Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations International, Inc. The live telesurgery was moderated by globally renowned robotic cardiac surgeon Dr. Husam H. Balkhy, M.D., President of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) and Professor of Surgery and Director of Robotic and Minimally Invasive Cardiac Surgery at the University of Chicago Medicine.
Patient-side support in Indore was seamlessly coordinated by Dr. Lalit Malik, Chief of Cardiac Surgery, Manipal Hospital, Jaipur; Dr. Ram Krishna Shukla, Cardiologist, and Dr. Bipin Arya, Anesthesiologist, both from Sri Aurobindo Institute of Medical Sciences (SAIMS), Indore, along with the dedicated teams from SSII and SAIMS.
The surgery was completed without any technical issues – with imperceptible latency, flawless precision, and seamless robotic control -demonstrating the exceptional performance of the SSI Mantra 3 Surgical Robotic System and its revolutionary telesurgery architecture.
Speaking on this achievement, SS Innovations International Inc.’s Founder, Chairman, and CEO, Dr. Sudhir Srivastava, said, “I would like to extend my gratitude to Vipul Patel, M.D., F.A.C.S., Chairman of the Society of Robotic Surgery for an opportunity at the SRS 2025 Conference, Dr. Mohit Bhandari, the IRCAD India team, and the entire SS Innovations team whose dedication and innovation made the world’s first intercontinental robotic cardiac telesurgery possible. This historic achievement not only demonstrates the advanced capabilities of our SSI Mantra 3 surgical robotic system but also further paves the way for redefining and democratizing global delivery of complex cardiac care, especially in regions with limited access to surgical expertise.”
Dr. Mohit Bhandari, President of IRCAD India and Founder & Director of Mohak Bariatric and Robotic Surgery Centre, Indore, said, “Performing a complex gastric bypass remotely, across continents, marks a transformative moment in surgical science. It’s not just about technological capability; it’s about bridging gaps in access to quality healthcare. The success of the SSI Mantra system proves that the future of safe, precise, and inclusive surgery is here, and it’s being shaped in India.”
SS Innovations International’s advanced SSI Mantra Surgical Robotic System, equipped with cutting-edge telesurgery capabilities, effectively overcomes traditional barriers such as travel, time, cost, and limited access to expert surgical care, establishing a more efficient, scalable, and equitable standard for both patients and surgeons.
To date, 35 telesurgeries – including 10 cardiac cases, and over 250 cardiac procedures have been successfully completed using the SSI Mantra system. Given that cardiac procedures rank among the most complex surgical interventions, this achievement stands as a strong testament to SSI Mantra’s precision and performance in both telesurgery and advanced soft-tissue surgeries. Additionally, more than 5,000 multi-specialty surgeries have been successfully performed using the SSI Mantra system, with no device-related adverse events reported.
SS Innovations International is the only surgical robotics company to have received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) for both tele-proctoring and telesurgery in India.
About SS Innovations International, Inc:
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSI Mantra” surgical robotic system and its comprehensive suite of “SSI Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations International plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
About SSI Mantra:
The SSI Mantra Surgical Robotic System, by SS Innovations International Inc., is a modular multi-arm system with many advanced technology features. It allows for the use of 3-5 robotic arms, has an open-faced ergonomic Surgeon Command Centre, 32-inch large 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the Surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are over 40 different types of robotic endo-surgical instruments that can be used for different specialties including Cardiac Surgery. The learning curve is short due to its very thoughtful and ergonomic design and user-friendly features.
Follow us on:
LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup/
